Trial Details

RECRUITING
Basic Information
Clinical ID c1344
Identifier NCT05327790
Trial Title LFMT vs Placebo in New Biologic Start for Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Lyophilized fecal microbiota (LFMT)|OTHER: Placebo
Participant Information
Sponsor University of Alberta
City Edmonton
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2022-06-03
Primary Completion Date 2025-03-31
Completion Date 2025-03-31